Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14.90%2.1B | -2.51%3.87B | -5.61%1.83B | 20.61%3.97B | 19.80%1.94B | -11.16%3.29B | -11.80%1.62B | 26.80%3.7B | 118.17%1.83B | -3.42%2.92B |
| Operating income | 14.90%2.1B | -2.51%3.87B | -5.61%1.83B | 20.61%3.97B | 19.80%1.94B | -11.16%3.29B | -11.80%1.62B | 26.80%3.7B | 118.17%1.83B | -3.42%2.92B |
| Cost of sales | -22.68%-1.12B | -11.26%-2.02B | -8.34%-910.96M | -15.92%-1.82B | -17.12%-840.86M | -6.12%-1.57B | -5.26%-717.94M | -8.71%-1.48B | -16.11%-682.1M | -34.56%-1.36B |
| Operating expenses | -22.68%-1.12B | -11.26%-2.02B | -8.34%-910.96M | -15.92%-1.82B | -17.12%-840.86M | -6.12%-1.57B | -5.26%-717.94M | -8.71%-1.48B | -16.11%-682.1M | -34.56%-1.36B |
| Gross profit | 7.17%981.58M | -14.18%1.84B | -16.32%915.92M | 24.89%2.15B | 21.95%1.09B | -22.66%1.72B | -21.92%897.59M | 42.58%2.22B | 355.98%1.15B | -22.51%1.56B |
| Administrative expenses | -9.38%-148.18M | -11.37%-298.23M | -1.17%-135.48M | 13.74%-267.78M | -31.10%-133.9M | 16.03%-310.42M | 3.12%-102.14M | -49.70%-369.66M | -15.87%-105.42M | 9.15%-246.94M |
| Special items of operating profit | 71.21%17.25M | 229.17%97.09M | -4.83%10.08M | -263.49%-75.16M | -72.08%10.59M | -94.25%45.97M | 39.12%37.91M | 3,082.02%800.12M | -26.09%27.25M | -85.98%25.15M |
| Operating profit | 7.61%850.64M | -9.01%1.64B | -18.61%790.52M | 24.02%1.8B | 16.55%971.27M | -45.17%1.45B | -22.22%833.37M | 98.41%2.65B | 441.12%1.07B | -30.33%1.34B |
| Financing income | -19.52%13.84M | -1.35%29.78M | 26.07%17.2M | -52.54%30.19M | -52.69%13.64M | 44.97%63.62M | 60.74%28.84M | 66.49%43.88M | 30.47%17.94M | -35.39%26.36M |
| Financing cost | 11.10%-221.68M | 14.43%-481.23M | 12.18%-249.35M | 10.09%-562.4M | 15.00%-283.93M | 15.82%-625.48M | 12.59%-334.03M | 7.79%-743.03M | 5.93%-382.15M | -95.94%-805.76M |
| Share of profits of associates | -4.69%39.11M | -82.58%35.01M | -56.72%41.04M | 68.90%201M | 46.85%94.81M | -36.32%119.01M | -36.68%64.57M | 175.54%186.87M | 698.22%101.97M | -74.16%67.82M |
| Share of profit from joint venture company | -3.98%33.91M | -4.50%72.3M | -0.73%35.31M | 42.16%75.71M | 35.11%35.57M | -30.76%53.26M | -30.87%26.33M | 36.06%76.92M | 634.70%38.09M | -36.29%56.53M |
| Earning before tax | 12.78%715.83M | -16.22%1.3B | -23.65%634.72M | 45.39%1.55B | 34.29%831.36M | -51.98%1.07B | -26.94%619.07M | 225.07%2.22B | 510.66%847.31M | -64.09%682.42M |
| Tax | -3.21%-172.48M | 22.00%-333.25M | 23.62%-167.12M | -30.45%-427.26M | -26.37%-218.79M | 23.05%-327.53M | 19.24%-173.14M | -53.07%-425.66M | -270.41%-214.39M | 8.94%-278.09M |
| After-tax profit from continuing operations | 16.20%543.34M | -14.02%964.36M | -23.67%467.6M | 52.02%1.12B | 37.37%612.57M | -58.84%737.81M | -29.54%445.94M | 343.37%1.79B | 339.56%632.93M | -74.65%404.34M |
| Earning after tax | 16.20%543.34M | -14.02%964.36M | -23.67%467.6M | 52.02%1.12B | 37.37%612.57M | -58.84%737.81M | -29.54%445.94M | 343.37%1.79B | 339.56%632.93M | -74.65%404.34M |
| Minority profit | 18.82%182.58M | -13.68%307.58M | -17.15%153.66M | 25.16%356.33M | 23.13%185.46M | -13.13%284.7M | -8.84%150.62M | 34.39%327.71M | 590.93%165.23M | -46.70%243.85M |
| Profit attributable to shareholders | 14.92%360.76M | -14.18%656.78M | -26.50%313.94M | 68.90%765.31M | 44.63%427.11M | -69.07%453.11M | -36.86%295.32M | 812.81%1.46B | 262.33%467.7M | -85.89%160.49M |
| Basic earnings per share | 14.93%0.2156 | -14.19%0.3925 | -26.52%0.1876 | 68.91%0.4574 | 44.65%0.2553 | -69.07%0.2708 | -36.85%0.1765 | 813.03%0.8756 | 262.31%0.2795 | -85.89%0.0959 |
| Diluted earnings per share | 14.93%0.2156 | -14.19%0.3925 | -26.52%0.1876 | 68.91%0.4574 | 44.73%0.2553 | -69.06%0.2708 | -36.89%0.1764 | 812.62%0.8752 | 262.31%0.2795 | -85.89%0.0959 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.